Search
for
Sort by
Research 30 of 291
- Cytochrome P450: A Target for Drug Development for Skin Diseases
- Interaction of antiretroviral medications with finasteride
- S100A8 induces cyclophosphamide-induced alopecia via NCF2/NOX2-mediated ferroptosis
- Structure-guided manipulation of the regioselectivity of the cyclosporine A hydroxylase CYP-sb21 from Sebekia benihana
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- Pharmacophore Modeling and Three Dimensional Database Searching for Drug Design Using Catalyst: Recent Advances
- Role for the Epidermal Growth Factor Receptor in Chemotherapy-Induced Alopecia
- Targets to treat androgen excess in polycystic ovary syndrome
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- A study on the extracts of Cuscuta reflexa Roxb. in treatment of cyclophosphamide induced alopecia
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- 138 Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles
- DUTASTERIDE AS AN EFFECTIVE TREATMENT IN ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- Ritlecitinib: First Approval
- Artepillin C and Other Herbal PAK1-blockers: Effects on Hair Cell Proliferation and Related PAK1-dependent Biological Function in Cell Culture
- Chemotherapy-Induced Hair Loss: The Use of Biomarkers for Predicting Alopecic Severity and Treatment Efficacy
- Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- HAIR LOSS ASSOCIATED WITH ESCITALOPRAM: DO SSRIs AFFECT MELATONIN AT THE HAIR FOLLICLE?
- Hair Growth Promoting and Anticancer Effects of p21-activated kinase 1 (PAK1) Inhibitors Isolated from Different Parts of Alpinia zerumbet
- Role of the soluble epoxide hydrolase in the hair follicle stem cell homeostasis and hair growth
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Selective Delivery of Tofacitinib Citrate to Hair Follicles Using Lipid-Coated Calcium Carbonate Nanocarrier Controls Chemotherapy-Induced Alopecia Areata
- Liquid Chromatography-Mass Spectrometry-Based In Vitro Metabolic Profiling Reveals Altered Enzyme Expressions in Eicosanoid Metabolism
- Testosterone, cytochrome P450, and cardiac hypertrophy
- Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
- Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models